Cédric Bürki

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Systemic Sclerosis

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Cyrille Lescop, Magdalena Birker, Christine Brotschi, Cédric Bürki, Keith Morrison, Sylvie Froidevaux, Stéphane Delahaye, Oliver Nayler, Martin H Bolli
Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases. Journal of medicinal chemistry 67 (4) (2024)
Cyrille Lescop, Magdalena Birker, Christine Brotschi, Cédric Bürki, Keith Morrison, Sylvie Froidevaux, Stéphane Delahaye, Oliver Nayler, Martin H Bolli
Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases. Journal of medicinal chemistry 67 (4) (2024)
Cyrille Lescop, Magdalena Birker, Christine Brotschi, Cédric Bürki, Keith Morrison, Sylvie Froidevaux, Stéphane Delahaye, Oliver Nayler, Martin H Bolli
Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases. Journal of medicinal chemistry (2024)